These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 28624481

  • 1. miR-34a overexpression predicts poor prognostic outcome in colorectal adenocarcinoma, independently of clinicopathological factors with established prognostic value.
    Rapti SM, Kontos CK, Christodoulou S, Papadopoulos IN, Scorilas A.
    Clin Biochem; 2017 Nov; 50(16-17):918-924. PubMed ID: 28624481
    [Abstract] [Full Text] [Related]

  • 2. High miR-96 levels in colorectal adenocarcinoma predict poor prognosis, particularly in patients without distant metastasis at the time of initial diagnosis.
    Rapti SM, Kontos CK, Papadopoulos IN, Scorilas A.
    Tumour Biol; 2016 Sep; 37(9):11815-11824. PubMed ID: 27044381
    [Abstract] [Full Text] [Related]

  • 3. Elevated expression of miR-24-3p is a potentially adverse prognostic factor in colorectal adenocarcinoma.
    Kerimis D, Kontos CK, Christodoulou S, Papadopoulos IN, Scorilas A.
    Clin Biochem; 2017 Apr; 50(6):285-292. PubMed ID: 27939727
    [Abstract] [Full Text] [Related]

  • 4. Upregulated miR-16 expression is an independent indicator of relapse and poor overall survival of colorectal adenocarcinoma patients.
    Diamantopoulos MA, Kontos CK, Kerimis D, Papadopoulos IN, Scorilas A.
    Clin Chem Lab Med; 2017 May 01; 55(5):737-747. PubMed ID: 27930363
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Heat shock protein beta 3 (HSPB3) is an unfavorable molecular biomarker in colorectal adenocarcinoma.
    Kalioraki MA, Artemaki PI, Sklirou AD, Kontos CK, Adamopoulos PG, Papadopoulos IN, Trougakos IP, Scorilas A.
    Mol Carcinog; 2020 Jan 01; 59(1):116-125. PubMed ID: 31709619
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Overexpression of microRNA-183 in human colorectal cancer and its clinical significance.
    Zhou T, Zhang GJ, Zhou H, Xiao HX, Li Y.
    Eur J Gastroenterol Hepatol; 2014 Feb 01; 26(2):229-33. PubMed ID: 24150523
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.